Engineered T cells promote long-term organ transplant acceptance

Organ transplant rejection is a serious downside in transplantation drugs. Suppressing the immune system to forestall organ rejection, nevertheless, opens the door to life-threatening infections. Researchers have now found a molecular method stopping rejection of the transplanted graft whereas concurrently sustaining the power to combat towards infections.